 | • レポートコード：20QY06-08127 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、肺気腫薬のグローバル市場について種類別（BB-3、EDO-66、MG-53、その他）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・肺気腫薬市場の概要 ・世界の主要地域別肺気腫薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の肺気腫薬市場規模2015-2026：種類別（BB-3、EDO-66、MG-53、その他） ・世界の肺気腫薬市場規模2015-2026：用途別（病院、クリニック、その他） ・肺気腫薬の北米市場規模2015-2020 ・肺気腫薬のヨーロッパ市場規模2015-2020 ・肺気腫薬の中国市場規模2015-2020 ・肺気腫薬の日本市場規模2015-2020 ・肺気腫薬の東南アジア市場規模2015-2020 ・肺気腫薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Angion Biomedica Corp.、ProMetic Life Sciences Inc.、rEVO Biologics, Inc.、SATT North SAS、TGV-Laboratories） ・肺気腫薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・肺気腫薬の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Emphysema Drug Market
The global Emphysema Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Emphysema Drug Scope and Market Size
The global Emphysema Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Emphysema Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Emphysema Drug market is segmented into
BB-3
EDO-66
MG-53
Others
Segment by Application, the Emphysema Drug market is segmented into
Hospital
Clinic
Others
The Emphysema Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Emphysema Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Emphysema Drug Market Share Analysis
Emphysema Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Emphysema Drug business, the date to enter into the Emphysema Drug market, Emphysema Drug product introduction, recent developments, etc.
The major vendors covered:
Angion Biomedica Corp.
ProMetic Life Sciences Inc.
rEVO Biologics, Inc.
SATT North SAS
TGV-Laboratories
…
Table of Contents
1 Emphysema Drug Market Overview
1.1 Emphysema Drug Product Scope
1.2 Emphysema Drug Segment by Type
1.2.1 Global Emphysema Drug Sales by Type (2020-2026)
1.2.2 BB-3
1.2.3 EDO-66
1.2.4 MG-53
1.2.5 Others
1.3 Emphysema Drug Segment by Application
1.3.1 Global Emphysema Drug Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Emphysema Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Emphysema Drug Sales Growth Rate (2015-2026)
1.4.2 Global Emphysema Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Emphysema Drug Price Trends (2015-2026)
2 Emphysema Drug Estimate and Forecast by Region
2.1 Global Emphysema Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Emphysema Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Emphysema Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Emphysema Drug Revenue Market Share by Region (2015-2020)
2.3 Global Emphysema Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Emphysema Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Emphysema Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Emphysema Drug Estimates and Projections (2015-2026)
2.4.2 Europe Emphysema Drug Estimates and Projections (2015-2026)
2.4.3 China Emphysema Drug Estimates and Projections (2015-2026)
2.4.4 Japan Emphysema Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Emphysema Drug Estimates and Projections (2015-2026)
2.4.6 India Emphysema Drug Estimates and Projections (2015-2026)
3 Global Emphysema Drug Competition Landscape by Players
3.1 Global Top Emphysema Drug Players by Sales (2015-2020)
3.2 Global Top Emphysema Drug Players by Revenue (2015-2020)
3.3 Global Emphysema Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Emphysema Drug as of 2019)
3.4 Global Emphysema Drug Average Price by Company (2015-2020)
3.5 Manufacturers Emphysema Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Emphysema Drug Players (Opinion Leaders)
4 Global Emphysema Drug Market Size by Type
4.1 Global Emphysema Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Emphysema Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Emphysema Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Emphysema Drug Price by Type (2014-2020)
4.2 Global Emphysema Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Emphysema Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Emphysema Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Emphysema Drug Price Forecast by Type (2021-2026)
5 Global Emphysema Drug Market Size by Application
5.1 Global Emphysema Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Emphysema Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Emphysema Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Emphysema Drug Price by Application (2015-2020)
5.2 Global Emphysema Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Emphysema Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Emphysema Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Emphysema Drug Price Forecast by Application (2021-2026)
3 North America Emphysema Drug Market Facts & Figures
3.2 North America Emphysema Drug Sales Market Share by Company (2015-2020)
3.3 North America Emphysema Drug Sales Market Share by Type (2015-2020)
3.4 North America Emphysema Drug Sales Market Share by Application (2015-2020)
4 Europe Emphysema Drug Market Facts & Figures
4.2 Europe Emphysema Drug Sales Market Share by Company (2015-2020)
4.3 Europe Emphysema Drug Sales Market Share by Type (2015-2020)
4.4 Europe Emphysema Drug Sales Market Share by Application (2015-2020)
5 China Emphysema Drug Market Facts & Figures
5.2 China Emphysema Drug Sales Market Share by Company (2015-2020)
5.3 China Emphysema Drug Sales Market Share by Type (2015-2020)
5.4 China Emphysema Drug Sales Market Share by Application (2015-2020)
6 Japan Emphysema Drug Market Facts & Figures
6.2 Japan Emphysema Drug Sales Market Share by Company (2015-2020)
6.3 Japan Emphysema Drug Sales Market Share by Type (2015-2020)
6.4 Japan Emphysema Drug Sales Market Share by Application (2015-2020)
7 Southeast Asia Emphysema Drug Market Facts & Figures
7.2 Southeast Asia Emphysema Drug Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Emphysema Drug Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Emphysema Drug Sales Market Share by Application (2015-2020)
8 India Emphysema Drug Market Facts & Figures
8.2 India Emphysema Drug Sales Market Share by Company (2015-2020)
8.3 India Emphysema Drug Sales Market Share by Type (2015-2020)
8.4 India Emphysema Drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Emphysema Drug Business
12.1 Angion Biomedica Corp.
12.1.1 Angion Biomedica Corp. Emphysema Drug Corporation Information
12.1.2 Angion Biomedica Corp. Emphysema Drug Business Overview and Total Revenue
12.1.3 Angion Biomedica Corp. Emphysema Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Angion Biomedica Corp. Emphysema Drug Products Offered
12.1.5 Angion Biomedica Corp. Recent Development
12.2 ProMetic Life Sciences Inc.
12.2.1 ProMetic Life Sciences Inc. Emphysema Drug Corporation Information
12.2.2 ProMetic Life Sciences Inc. Emphysema Drug Business Overview and Total Revenue
12.2.3 ProMetic Life Sciences Inc. Emphysema Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 ProMetic Life Sciences Inc. Emphysema Drug Products Offered
12.2.5 ProMetic Life Sciences Inc. Recent Development
12.3 rEVO Biologics, Inc.
12.3.1 rEVO Biologics, Inc. Emphysema Drug Corporation Information
12.3.2 rEVO Biologics, Inc. Emphysema Drug Business Overview and Total Revenue
12.3.3 rEVO Biologics, Inc. Emphysema Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 rEVO Biologics, Inc. Emphysema Drug Products Offered
12.3.5 rEVO Biologics, Inc. Recent Development
12.4 SATT North SAS
12.4.1 SATT North SAS Emphysema Drug Corporation Information
12.4.2 SATT North SAS Emphysema Drug Business Overview and Total Revenue
12.4.3 SATT North SAS Emphysema Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 SATT North SAS Emphysema Drug Products Offered
12.4.5 SATT North SAS Recent Development
12.5 TGV-Laboratories
12.5.1 TGV-Laboratories Emphysema Drug Corporation Information
12.5.2 TGV-Laboratories Emphysema Drug Business Overview and Total Revenue
12.5.3 TGV-Laboratories Emphysema Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 TGV-Laboratories Emphysema Drug Products Offered
12.5.5 TGV-Laboratories Recent Development
…
13 Emphysema Drug Manufacturing Cost Analysis
13.1 Emphysema Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Emphysema Drug
13.4 Emphysema Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Emphysema Drug Distributors List
14.3 Emphysema Drug Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Emphysema Drug Sales (K Pcs) Growth Rate by Type (2020-2026)
Table 2. Global Emphysema Drug Sales (K Pcs) Comparison by Application (2020-2026)
Table 3. Global Market Emphysema Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Emphysema Drug Sales (K Pcs) by Region (2015-2020)
Table 5. Global Emphysema Drug Sales Market Share by Region (2015-2020)
Table 6. Global Emphysema Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Emphysema Drug Revenue Share by Region (2015-2020)
Table 8. Global Emphysema Drug Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Emphysema Drug Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Emphysema Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Emphysema Drug Revenue Share Forecast by Region (2021-2026)
Table 12. Global Emphysema Drug (K Pcs) of Key Companies (2015-2020)
Table 13. Global Emphysema Drug Sales Share by Company (2015-2020)
Table 14. Global Emphysema Drug Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Emphysema Drug Revenue Share by Company (2015-2020)
Table 16. Global Emphysema Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Emphysema Drug as of 2019)
Table 17. Global Emphysema Drug Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Emphysema Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Emphysema Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Emphysema Drug Players
Table 22. Global Emphysema Drug Sales (K Pcs) by Type (2015-2020)
Table 23. Global Emphysema Drug Sales Share by Type (2015-2020)
Table 24. Global Emphysema Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Emphysema Drug Price (K Pcs) by Type (2015-2020)
Table 26. Global Emphysema Drug Sales Share by Type (2021-2026)
Table 27. Global Emphysema Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Emphysema Drug Revenue Share by Type (2021-2026)
Table 29. Global Emphysema Drug Price (K Pcs) by Type (2021-2026)
Table 30. Global Emphysema Drug Sales (K Pcs) by Application (2015-2020)
Table 31. Global Emphysema Drug Sales Share by Application (2015-2020)
Table 32. Global Emphysema Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Emphysema Drug Price (K Pcs) by Application (2015-2020)
Table 34. Global Emphysema Drug Sales (K Pcs) by Application (2021-2026)
Table 35. Global Emphysema Drug Sales Share by Application (2021-2026)
Table 36. Global Emphysema Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Emphysema Drug Revenue Share by Application (2021-2026)
Table 38. Global Emphysema Drug Price (K Pcs) by Application (2021-2026)
Table 39. United States Emphysema Drug Sales (K Pcs) by Company (2015-2020)
Table 40. United States Emphysema Drug Sales Market Share by Company (2015-2020)
Table 41. United States Emphysema Drug Sales (K Pcs) by Type (2015-2020)
Table 42. United States Emphysema Drug Sales Market Share by Type (2015-2020)
Table 43. United States Emphysema Drug Sales (K Pcs) by Application (2015-2020)
Table 44. United States Emphysema Drug Sales Market Share by Application (2015-2020)
Table 45. Europe Emphysema Drug Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Emphysema Drug Sales Market Share by Company (2015-2020)
Table 47. Europe Emphysema Drug Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Emphysema Drug Sales Market Share by Type (2015-2020)
Table 49. Europe Emphysema Drug Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Emphysema Drug Sales Market Share by Type (2015-2020)
Table 51. China Emphysema Drug Sales (K Pcs) by Company (2015-2020)
Table 52. China Emphysema Drug Sales Market Share by Company (2015-2020)
Table 53. China Emphysema Drug Sales (K Pcs) by Type (2015-2020)
Table 54. China Emphysema Drug Sales Market Share by Type (2015-2020)
Table 55. China Emphysema Drug Sales (K Pcs) by Application (2015-2020)
Table 56. China Emphysema Drug Sales Market Share by Application (2015-2020)
Table 57. Japan Emphysema Drug Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Emphysema Drug Sales Market Share by Company (2015-2020)
Table 59. Japan Emphysema Drug Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Emphysema Drug Sales Market Share by Type (2015-2020)
Table 61. Japan Emphysema Drug Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Emphysema Drug Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Emphysema Drug Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Emphysema Drug Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Emphysema Drug Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Emphysema Drug Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Emphysema Drug Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Emphysema Drug Sales Market Share by Application (2015-2020)
Table 69. India Emphysema Drug Sales (K Pcs) by Company (2015-2020)
Table 70. India Emphysema Drug Sales Market Share by Company (2015-2020)
Table 71. India Emphysema Drug Sales (K Pcs) by Type (2015-2020)
Table 72. India Emphysema Drug Sales Market Share by Type (2015-2020)
Table 73. India Emphysema Drug Sales (K Pcs) by Application (2015-2020)
Table 74. India Emphysema Drug Sales Market Share by Application (2015-2020)
Table 75. Angion Biomedica Corp. Corporation Information
Table 76. Angion Biomedica Corp. Description and Business Overview
Table 77. Angion Biomedica Corp. Emphysema Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Angion Biomedica Corp. Emphysema Drug Product
Table 79. Angion Biomedica Corp. Recent Development
Table 80. ProMetic Life Sciences Inc. Corporation Information
Table 81. ProMetic Life Sciences Inc. Description and Business Overview
Table 82. ProMetic Life Sciences Inc. Emphysema Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. ProMetic Life Sciences Inc. Emphysema Drug Product
Table 84. ProMetic Life Sciences Inc. Recent Development
Table 85. rEVO Biologics, Inc. Corporation Information
Table 86. rEVO Biologics, Inc. Description and Business Overview
Table 87. rEVO Biologics, Inc. Emphysema Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. rEVO Biologics, Inc. Emphysema Drug Product
Table 89. rEVO Biologics, Inc. Recent Development
Table 90. SATT North SAS Corporation Information
Table 91. SATT North SAS Description and Business Overview
Table 92. SATT North SAS Emphysema Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. SATT North SAS Emphysema Drug Product
Table 94. SATT North SAS Recent Development
Table 95. TGV-Laboratories Corporation Information
Table 96. TGV-Laboratories Description and Business Overview
Table 97. TGV-Laboratories Emphysema Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. TGV-Laboratories Emphysema Drug Product
Table 99. TGV-Laboratories Recent Development
Table 100. Production Base and Market Concentration Rate of Raw Material
Table 101. Key Suppliers of Raw Materials
Table 102. Emphysema Drug Distributors List
Table 103. Emphysema Drug Customers List
Table 104. Market Key Trends
Table 105. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 106. Key Challenges
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Emphysema Drug Product Picture
Figure 2. Global Emphysema Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Emphysema Drug Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Clinic Examples
Figure 8. Others Examples
Figure 9. Global Emphysema Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 10. Global Emphysema Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Emphysema Drug Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 12. Global Emphysema Drug Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Emphysema Drug Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Emphysema Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Emphysema Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 16. Europe Emphysema Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Emphysema Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Emphysema Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Emphysema Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Emphysema Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Emphysema Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Emphysema Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Emphysema Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Emphysema Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Emphysema Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Emphysema Drug Players Market Share by Revenue in Emphysema Drug 2015 & 2019
Figure 27. Emphysema Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Emphysema Drug Revenue Share by Type (2015-2020)
Figure 29. Global Emphysema Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Emphysema Drug Revenue Share by Application (2015-2020)
Figure 31. Global Emphysema Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Emphysema Drug Sales Market Share by Type in 2019
Figure 33. United States Emphysema Drug Sales Market Share by Type in 2019
Figure 34. Europe Emphysema Drug Sales Market Share by Company in 2019
Figure 35. Europe Emphysema Drug Sales Market Share by Type in 2019
Figure 36. Europe Emphysema Drug Sales Market Share by Application in 2019
Figure 37. China Emphysema Drug Sales Market Share by Company in 2019
Figure 38. China Emphysema Drug Sales Market Share by Type in 2019
Figure 39. China Emphysema Drug Sales Market Share by Application in 2019
Figure 40. Japan Emphysema Drug Sales Market Share by Company in 2019
Figure 41. Japan Emphysema Drug Sales Market Share by Type in 2019
Figure 42. Japan Emphysema Drug Sales Market Share by Application in 2019
Figure 43. Southeast Asia Emphysema Drug Sales Market Share by Company in 2019
Figure 44. Southeast Asia Emphysema Drug Sales Market Share by Type in 2019
Figure 45. Southeast Asia Emphysema Drug Sales Market Share by Application in 2019
Figure 46. India Emphysema Drug Sales Market Share by Company in 2019
Figure 47. India Emphysema Drug Sales Market Share by Type in 2019
Figure 48. India Emphysema Drug Sales Market Share by Application in 2019
Figure 49. Angion Biomedica Corp. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. ProMetic Life Sciences Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. rEVO Biologics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. SATT North SAS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. TGV-Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Key Raw Materials Price Trend
Figure 55. Manufacturing Cost Structure of Emphysema Drug
Figure 56. Manufacturing Process Analysis of Emphysema Drug
Figure 57. Emphysema Drug Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Porter's Five Forces Analysis
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
象皮病薬の世界市場レポート2020 Market Analysis and Insights: Global Elephantiasis Drug Market The global Elephantiasis Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Elephantiasis Drug Scope and Market Size The global Elephantias…- フィブリノーゲン欠乏症薬の世界市場レポート2020 Market Analysis and Insights: Global Fibrinogen Deficiency Drug Market The global Fibrinogen Deficiency Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Fibrinogen Deficiency Drug Scope and Market Siz…
- アレルギー鼻炎薬の世界市場レポート2020 Market Analysis and Insights: Global Allergy Rhinitis Drug Market The global Allergy Rhinitis Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Allergy Rhinitis Drug Scope and Market Size The global Al…
- 細菌性赤痢薬の世界市場レポート2020 Market Analysis and Insights: Global Bacillary Dysentery Drug Market The global Bacillary Dysentery Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Bacillary Dysentery Drug Scope and Market Size The …
- 前部ブドウ膜炎薬の世界市場レポート2020 Market Analysis and Insights: Global Anterior Uveitis Drug Market The global Anterior Uveitis Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Anterior Uveitis Drug Scope and Market Size The global An…